Company
Auckland University's commercialisation arm
Auckland, OS
Every investor coverage indicates participated in a round Uniservices raised.
Companies Uniservices acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Evelyn Body | Director of Commercialisation | Brandon Capital portfolio |
Stories naming Uniservices. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Medtech firm Kitea Health has wrapped an oversubscribed $13 million round, with Icehouse Ventures leading, to fund planned American human trials of its implanted pressure sensor.
Auckland University spinout TamoRx has secured NZ$15.25 million to develop a new cancer immunotherapy, in a round led by Brandon Capital alongside the university's Inventors' Fund, with a Callaghan Innovation grant included.